Posts by Admin BioAlps

The Geneva-based immune-oncology startup contributing to the SARS-CoV-2 vaccine development   The following article is part of BioAlps’ testimonial series and was written by Mrs Ksenija Pavletic, Board Member at MaxiVAX. Our series aims to provide a platform for the different life sciences actors from western Switzerland, who are active in finding and developing solutions…

Supporting the Company’s Global Expansion to Meet Growing Clinical and Biopharma Demand for Data-Driven Medicine   SOPHiA GENETICS, global leader in Data-Driven Medicine, announced today the closing of a $110 million financing round to enter into the next stage of its expansion, with a focus on supporting the growing clinical and biopharma demand for Data-Driven…

A rapid diagnostic test for the detection of antibodies against COVID-19   The following article is part of BioAlps’ testimonial series and was written by Mr Percevent Ducrest, CEO at GaDia. Our series aims to provide a platform for the different life sciences actors from western Switzerland, who are active in finding and developing solutions…

A device capable of autonomously screening the body temperature to detect fever symptoms caused by viral or bacterial infections   The following article is part of BioAlps’ testimonial series and was written by Mr Adrian Shajkofci, Founder of Coronasense. Our series aims to provide a platform for the different life sciences actors from western Switzerland,…

Leveraging CERN’s novel technologies and know-how to develop health applications   The following article is part of BioAlps’ testimonial series and was written by Dr Beniamino Di Girolamo, Principal Applied Physicist and CERN Against COVID-19 Taskforce coordinator. Our series aims to provide a platform for the different life sciences actors from western Switzerland, who are…

SwissCovid app | Privacy by design   The following article is part of BioAlps’ testimonial series and was written by Prof Carmela Troncoso, Head of EPFL’s Security and Privacy Engineering Lab (SPRING). Our series aims to provide a platform for the different life sciences actors from western Switzerland, who are active in finding and developing solutions…

Reorganisation of teams and work streams to ensure the production and delivery of life-saving products while protecting the health of 650 employees   The following article is part of BioAlps’ testimonial series and was written by Mr Juergen Wagner Head of Takeda Neuchâtel Manufacturing Site. Our series aims to provide a platform for the different…

Digital solutions, fundamental and clinical research, and organisational process redesign to support the fight against COVID and enhance the physicians-patients relationship   The following article is part of BioAlps’ testimonial series and was written by Mrs Helena Bornet dit Vorgeat Concerto and Vision 20/20 Projects Lead at HUG Innovation Center. Our series aims to provide…

Development of vaccine, drugs and robotic disinfection equipment to fight COVID-19   The following article is part of BioAlps’ testimonial series and was written by Mr Gilles Salomon, Jura Branch Director at JAG Process Solutions. Our series aims to provide a platform for the different life sciences actors from western Switzerland, who are active in…

EBAMed receives a EUR 2.4 million grant from the EU Horizon 2020 Research and Innovation Program   EBAMed is glad to announce the award of a non-dilutive EUR 2.4 M grant by the Enhanced European Innovation Council (EIC) within the framework of the competitive EU Horizon 2020 Research and Innovation Program under grant agreement No…